Contact Us
Drug Search Results
More Filters [+]

Sofinicline

Alternative Names: sofinicline, abt-894, abt894, abt 894
Latest Update: 2021-10-29
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: nAChR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Abbott Laboratories
Company Location: ABBOTT PARK IL 60064-3500
Company CEO: Robert B. Ford
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sofinicline

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Neuropathic Pain|Neuralgia|Polyneuropathies|Peripheral Nervous System Diseases|Attention Deficit Disorder with Hyperactivity

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
18-1100.cc

N/A

Not yet recruiting

Chronic Pain|Musculoskeletal Pain

2017-10-02

2007-001140-47

P2

Completed

Neuropathic Pain

2008-12-02

M10-014

P2

Completed

Neuralgia|Neuropathic Pain

2008-12-01

2007-001139-71

P2

Completed

Neuropathic Pain

2008-10-07

Recent News Events

Date

Type

Title

10/29/2021

PubMed

 Different Drugs for the Treatment of Painful Diabetic Peripheral Neuropathy: A Meta-Analysis.

10/01/2021

PubMed

 Bicyclic Pyrrolidines for Medicinal Chemistry via [3 + 2]-Cycloaddition.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions